Ramipril

Ramipril (marketed as Prilace by Arrow Pharmaceuticals in Australia, Ramipro by Westfield Pharma in the Philippines, Tritace by Sanofi-Aventis and Altace by King Pharmaceuticals in the United States, and Altace by Sanofi in Canada) is an angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure.